New Delhi: In what comes as a major relief for the people suffering from Covid-19, the Central Government on Saturday slashed prices of the anti-viral drug Remdesivir by nearly Rs 2,000 per injection.


Remdesivir will now be sold for as less as Rs 899, as per the new list announced in a press note by Dr Vinod Kotwal, Member Advisor, Department of Pharmaceuticals, Ministry of Chemicals and Fertilisers.


ALSO READ | Delhi Covid Crisis: CM Kejriwal Informs Shortage Of Oxygen, ICU Beds As Capital Records Over 24,000 Cases In 24 Hrs


Below are the revised price rates of the anti-viral drug:



  • Cadila Healthcare Ltd REMDAC (from Rs 2,800 to Rs 899)


  • Syngene International Ltd (Biocon Biologics India) RemWin (from Rs 3,950 to Rs 2,450)


  • Reddy's Laboratories Ltd REDYX from (Rs 5,400 to Rs 2,700)


  • Hetero Healthcare Ltd COVIFOR from (Rs 5,400 to Rs 3,490)

  • Cipla Ltd CIPREMI from (Rs 4,000 to Rs 3,000)


  • Mylan Pharmaceuticals Pvt Ltd DESREM (from Rs 4,800 to Rs 3,400)


  • Jubilant Generics Ltd JUBI-R from (Rs 4,700 to Rs 3,400)


The reduction in price comes amid the shortage of Remdesivir following an unprecedented surge in Covid-19 cases in the country.


ALSO READ | 'Kumbh Mela Returnees Will Distribute Corona As Prasad': Mumbai Mayor Demands Full Lockdown


The Centre earlier held a meeting with all-existing drug manufacturers to discuss the increase in production and supply and also to reduce the price of Remdesivir injection as several states, including the worst-affected Maharashtra, demanded adequate supply of the anti-viral drug.


Earlier on April 11, the Centre prohibited exports of injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API) till the covid situation in the country improves while initiating various steps to ensure easy access of the anti-viral drug to patients and hospitals.